Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Human Insulin Market to reach USD 72.97 billion by 2028.

Global Human Insulin Market Size study, By Product Type (Insulin Analogs and Biosimilars (Rapid-acting, Long-acting, Premixed), Human Insulin Biologics (Short-acting, Intermediate-acting, Premixed)), By Type (Insulin Analogs and Biosimilars (Long-Acting Biosimilars, Rapid-Acting Biosimilars, Premixed Biosimilars), HI Biologics (Short-Acting Biologics, Intermediate-Acting Biologics, Premixed Biologics)), By Delivery Devices (Pens, Pen Needles, Syringes), By Brand (Insulin Analogs and Biosimilars (Lantus, NovoRapid/Novolog, Humalog, Other Brands), Human Insulin Biologics (Actrapid, Insulatard, and Mixtard, Humulin, Insuman)), By Application (Type I Diabetes, Type II Diabetes), and Regional Forecasts 2022-2028

Product Code: HLSHS-56873554
Publish Date: 20-04-2022
Page: 200

Global Human Insulin Market is valued approximately USD 42.30 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.1% over the forecast period 2022-2028.

Human insulin works by assisting move sugar from the blood into further body tissues where it is devoured for energy and it also prevents the liver from producing more sugar. Human insulin is manufactured through genetic engineering by injecting insulin-producing genes into bacteria. This technique has reduced the cost of manufacturing by some manifolds. The growing number of diabetic patients, increasing demand for the HI analogs, technological developments in HI delivery devices, presence of favorable medical reimbursement scenarios in various regions are the primary factors that are augmenting the market demand around the world. For instance, according to the International Diabetic Federation (IDF), in 2019, there were nearly 463 million adults aged between 20-79 years were suffering from diabetes. Also, the amount is anticipated to reach around 700 million by 2045. Consequentially, the growing prevalence of diabetes is fostering the demand for human insulin, which, in turn, accelerates market growth in the near future. However, high product manufacturing costs and stringent regulatory requirements for product approval impede the growth of the market over the forecast period of 2022-2028. Also, the development of the emerging markets and expected patent expiry of key HI drugs is anticipated to act as a catalyzing factor for the market demand during the forecast period.

The key regions considered for the global Human Insulin market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing responsiveness to benefits offered by human insulin in diabetes treatment and the presence of major market players in the region. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as growing incidences of diabetes, as well as escalating population, would create lucrative growth prospects for the Human Insulin market across the Asia-Pacific region.

Major market players included in this report are:
Sanofi S.A.
Novo Nordisk A/S
Eli Lilly and Company
Biocon Ltd.
Julphar
Ypsomed AG
Becton, Dickinson and Company
Wockhardt Ltd.
B. Braun Meselgen AG
Biodel Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Insulin Analogs and Biosimilars
Rapid-acting
Long-acting
Premixed
Human Insulin Biologics
Short-acting
Intermediate-acting
Premixed
By Type:
Insulin Analogs and Biosimilars
Long-Acting Biosimilars
Rapid-Acting Biosimilars
Premixed Biosimilars
HI Biologics
Short-Acting Biologics
Intermediate-Acting Biologics
Premixed Biologics
By Delivery Devices:
Pens
Pen Needles
Syringes
By Brand:
Insulin Analogs and Biosimilars
Lantus
NovoRapid/Novolog
Humalog
Other Brands
Human Insulin Biologics
Actrapid, Insulatard, and Mixtard
Humulin
Insuman
By Application:
Type I Diabetes
Type II Diabetes
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Human Insulin Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Human Insulin Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Human Insulin Market, by Product Type, 2020-2028 (USD Billion)
1.2.3. Global Human Insulin Market, by Type, 2020-2028 (USD Billion)
1.2.4. Global Human Insulin Market, by Delivery Devices, 2020-2028 (USD Billion)
1.2.5. Global Human Insulin Market, by Brand, 2020-2028 (USD Billion)
1.2.6. Global Human Insulin Market, by Application, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Human Insulin Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Human Insulin Market Dynamics
3.1. Human Insulin Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing incidences of diabetic patients
3.1.1.2. Technological advancements in HI delivery devices
3.1.2. Market Challenges
3.1.2.1. High product manufacturing costs
3.1.2.2. Stringent regulatory requirements for product approval
3.1.3. Market Opportunities
3.1.3.1. Development of the emerging Markets
3.1.3.2. Expected patent expiry of key HI drugs
Chapter 4. Global Human Insulin Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Human Insulin Market, by Product Type
6.1. Market Snapshot
6.2. Global Human Insulin Market by Product Type, Performance – Potential Analysis
6.3. Global Human Insulin Market Estimates & Forecasts by Product Type 2018-2028 (USD Billion)
6.4. Human Insulin Market, Sub Segment Analysis
6.4.1. Insulin Analogs and Biosimilars
6.4.1.1. Rapid-acting
6.4.1.2. Long-acting
6.4.1.3. Premixed
6.4.2. Human Insulin Biologics
6.4.2.1. Short-acting
6.4.2.2. Intermediate-acting
6.4.2.3. Premixed
Chapter 7. Global Human Insulin Market, by Type
7.1. Market Snapshot
7.2. Global Human Insulin Market by Type, Performance – Potential Analysis
7.3. Global Human Insulin Market Estimates & Forecasts by Type 2018-2028 (USD Billion)
7.4. Human Insulin Market, Sub Segment Analysis
7.4.1. Insulin Analogs and Biosimilars
7.4.1.1. Long-Acting Biosimilars
7.4.1.2. Rapid-Acting Biosimilars
7.4.1.3. Premixed Biosimilars
7.4.2. HI Biologics
7.4.2.1. Short-Acting Biologics
7.4.2.2. Intermediate-Acting Biologics
7.4.2.3. Premixed Biologics
Chapter 8. Global Human Insulin Market, by Delivery Devices
8.1. Market Snapshot
8.2. Global Human Insulin Market by Delivery Devices, Performance – Potential Analysis
8.3. Global Human Insulin Market Estimates & Forecasts by Delivery Devices 2018-2028 (USD Billion)
8.4. Human Insulin Market, Sub Segment Analysis
8.4.1. Pens
8.4.2. Pen Needles
8.4.3. Syringes
Chapter 9. Global Human Insulin Market, by Brand
9.1. Market Snapshot
9.2. Global Human Insulin Market by Brand, Performance – Potential Analysis
9.3. Global Human Insulin Market Estimates & Forecasts by Brand 2018-2028 (USD Billion)
9.4. Human Insulin Market, Sub Segment Analysis
9.4.1. Insulin Analogs and Biosimilars
9.4.1.1. Lantus
9.4.1.2. NovoRapid/Novolog
9.4.1.3. Humalog
9.4.1.4. Other Brands
9.4.2. Human Insulin Biologics
9.4.2.1. Actrapid, Insulatard, and Mixtard
9.4.2.2. Humulin
9.4.2.3. Insuman
Chapter 10. Global Human Insulin Market, by Application
10.1. Market Snapshot
10.2. Global Human Insulin Market by Application, Performance – Potential Analysis
10.3. Global Human Insulin Market Estimates & Forecasts by Application 2018-2028 (USD Billion)
10.4. Human Insulin Market, Sub Segment Analysis
10.4.1. Type I Diabetes
10.4.2. Type II Diabetes
Chapter 11. Global Human Insulin Market, Regional Analysis
11.1. Human Insulin Market, Regional Market Snapshot
11.2. North America Human Insulin Market
11.2.1. U.S. Human Insulin Market
11.2.1.1. Product Type estimates & forecasts, 2018-2028
11.2.1.2. Type estimates & forecasts, 2018-2028
11.2.1.3. Delivery Devices estimates & forecasts, 2018-2028
11.2.1.4. Brand estimates & forecasts, 2018-2028
11.2.1.5. Application estimates & forecasts, 2018-2028
11.2.2. Canada Human Insulin Market
11.3. Europe Human Insulin Market Snapshot
11.3.1. U.K. Human Insulin Market
11.3.2. Germany Human Insulin Market
11.3.3. France Human Insulin Market
11.3.4. Spain Human Insulin Market
11.3.5. Italy Human Insulin Market
11.3.6. Rest of Europe Human Insulin Market
11.4. Asia-Pacific Human Insulin Market Snapshot
11.4.1. China Human Insulin Market
11.4.2. India Human Insulin Market
11.4.3. Japan Human Insulin Market
11.4.4. Australia Human Insulin Market
11.4.5. South Korea Human Insulin Market
11.4.6. Rest of Asia Pacific Human Insulin Market
11.5. Latin America Human Insulin Market Snapshot
11.5.1. Brazil Human Insulin Market
11.5.2. Mexico Human Insulin Market
11.6. Rest of The World Human Insulin Market
Chapter 12. Competitive Intelligence
12.1. Top Market Strategies
12.2. Company Profiles
12.2.1. Sanofi S.A.
12.2.1.1. Key Information
12.2.1.2. Overview
12.2.1.3. Financial (Subject to Data Availability)
12.2.1.4. Product Type Summary
12.2.1.5. Recent Developments
12.2.2. Novo Nordisk A/S
12.2.3. Eli Lilly and Company
12.2.4. Biocon Ltd.
12.2.5. Julphar
12.2.6. Ypsomed AG
12.2.7. Becton, Dickinson and Company
12.2.8. Wockhardt Ltd.
12.2.9. B. Braun Meselgen AG
12.2.10. Biodel Inc.
Chapter 13. Research Process
13.1. Research Process
13.1.1. Data Mining
13.1.2. Analysis
13.1.3. Market Estimation
13.1.4. Validation
13.1.5. Publishing
13.2. Research Attributes
13.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now